Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 113, Issue 5, Pages 735-745
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1038/s41395-018-0026-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plecanatide and Dolcanatide, Guanylate Cyclase-C Agonists, Attenuate Paracellular Permeability and Enhance Normal Localization of Tight Junctional Proteins to Maintain Intestinal Barrier Function
- (2017) Anusha Thadi et al. GASTROENTEROLOGY
- Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
- (2017) Michael DeMicco et al. Therapeutic Advances in Gastroenterology
- Bowel Disorders
- (2016) Brian E. Lacy et al. GASTROENTEROLOGY
- Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation
- (2016) L. Neri et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking and Disease Burden
- (2015) Joel J Heidelbaugh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Guanylate Cyclase C Agonists: Emerging Gastrointestinal Therapies and Actions
- (2015) Michael Camilleri GASTROENTEROLOGY
- Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases
- (2015) A. Jarmuż et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Tight junctions and IBS - the link between epithelial permeability, low-grade inflammation, and symptom generation?
- (2014) T. Piche NEUROGASTROENTEROLOGY AND MOTILITY
- Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS
- (2013) E. Wilcz-Villega et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation
- (2013) L Ashley Blackshaw et al. Expert Review of Gastroenterology & Hepatology
- Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
- (2012) Rebecca M. Lovell et al. Clinical Gastroenterology and Hepatology
- Intestinal barrier function in health and gastrointestinal disease
- (2012) M. Camilleri et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype
- (2011) Nathalie Bertiaux-Vandaële et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Uroguanylin Regulates Net Fluid Secretion via the NHE2 Isoform of the Na+/H+ Exchanger in an Intestinal Cellular Model
- (2011) Roxana Toriano et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome
- (2011) Marco DiBonaventura et al. CURRENT MEDICAL RESEARCH AND OPINION
- Loss of Guanylyl Cyclase C (GCC) Signaling Leads to Dysfunctional Intestinal Barrier
- (2011) Xiaonan Han et al. PLoS One
- Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
- (2010) Robert W. Busby et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- International Survey of Patients With IBS
- (2009) Douglas A. Drossman et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started